SNOA
Sonoma Pharmaceuticals Inc
NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.14
-0.87% today
Updated 2026-10-28
Market cap
$5.36M
P/E ratio
—
P/S ratio
0.25x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Sonoma Pharmaceuticals Inc (SNOA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.14
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$2.07
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -10.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.